William Parker
Pediatrics · Shreveport, LANPI 1174521785
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $249 and has fallen 63.2% since, to $92 in 2025.
Across 44 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$166
- Ironshore Pharmaceuticals Inc.$148
- Corium, LLC$81
- Cumberland Pharmaceuticals, Inc.$78
- GSK$72
- Sanofi Pasteur Inc.$42
- plus $219 from 11 others
Across 32 payments — averaging $10,678 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$234K
- Astrazeneca UK Limited$75K
- Sanofi Pasteur Inc.$30K
- Sanofi US Services Inc.$3K
What the payments were for
- Food & beverage$807100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 8 | $166 |
| Ironshore Pharmaceuticals Inc. | 9 | $148 |
| Corium, LLC | 4 | $81 |
| Cumberland Pharmaceuticals, Inc. | 3 | $78 |
| GSK | 5 | $72 |
| Sanofi Pasteur Inc. | 2 | $42 |
| Tris Pharma Inc | 2 | $32 |
| Merck | 2 | $31 |
| AbbVie | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| AstraZeneca | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Neos Therapeutics, LP | 1 | $15 |
| Pfizer | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$807 in reported general payments places this provider in the 70th percentile of 913 pediatrics providers in Louisiana.
Other pediatrics in Shreveport
- Neslihan GungorShreveport$16K
- Mamatha MandavaShreveport$8K
- Kendra LandryShreveport$5K
- Lori PhillipsShreveport$3K
- Margaret CrittellShreveport$3K
- Donald MackShreveport$3K
- Mackey QuinlanShreveport$3K
- Stuart ClarkShreveport$2K
- Corey HebertGretna$1.3M
- Katie QueenBogalusa$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.